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1. Introduction  
Germ cells (GC) appeared very early in embryonic development and are maintained over 
life period in order to give rise to the gametes of organisms that reproduce sexually (Fig. 1). 
These cells provide continuous tie between the generations (Donovan & de Miguel 2003, 
McLaren 2003). 
 
 
Fig. 1. Germ cells lifespan. 
In mammals, the specification of GC begins during cleavage; GC first appears near the gut 
and further migrates to the developing gonads. The lineage of GC is called germ line. They 
are unique cells, which undergo cell division of two types, mitosis and meiosis, in contrast 
to somatic cells of mammal’s body, which only divide by mitosis. Accordingly to Fig. 2 
following further differentiation GC can be transformed into mature gamete, either eggs or 
sperm (Adams & McLaren, 2002). There is growing evidence for effects of environmental 
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chemicals on the various early stages of GC and gametes development (Baillie et al., 2003). 
Therefore, elucidating of the mechanisms controlling GC and gametes development is 
crucial for understanding an etiology of various aspects of infertility. Due to the complexity 
of natural process of mature gametes formation from GC and in order to provide in vitro 
model of GC development and fate, embryonic stem (ES) cells were recently used (Nagy et 
al., 2008).  
 
 
Fig. 2. Gametogenesis. 
In vitro derivation of GC and male- and female-like gametes from pluripotent mouse 
embryonic stem (mES) cells was achieved using adherent cells (monolayer cell culture) and 
three-dimensional structures called embryoid bodies (EB), which present in vitro model of 
pre-implantation embryos, however chaotically organized.  A variety of culture media have 
been also tested. These protocols are contradictory in respect of timing needs for GC 
generation from mES cells, which varies from 11 to 43 days in different studies; summarized 
in Fig. 3 and 4. The other difficulty is a lack of appropriate molecular markers for the 
characterization of the undifferentiated GC. The markers of early primordial GC (PGC) such 
as Stella, C-kit and Fragillis have key roles in GC competency and development, while Dazl 
and Vasa express in premeiotic GC. However, all these genes are also expressed in ES cells 
(Aflatoonian and Moore, 2006; Ko & Schöler, 2006; Nagano, 2007; Daley, 2007; Hua and 
Sidhu, 2008; Marques-Mari, 2009). 
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Fig. 3. Presumptive female GC and gametes derived from ES cells. 
Genetically modified ES cells using fluorescent proteins linked to specific gene promoters 
(genes implicated in pluripotency or GC line fate) have been used in order to pre-select 
committed PGC and to provide more efficient harvesting of mature GC (Hubner et al., 2003, 
Toyooka et al., 2003, Nayernia et al., 2006). Although genetic modification facilitates the 
process of GC isolation, in the future such genetically modified GC (GM-GC) would have 
limited practical utilization especially in clinical procedures. Therefore, other research 
groups have a propensity to establish efficient protocols of GC isolation from native ES cells 
(Geijsen et al., 2004; Lacham-Kaplan et al., 2006; Kerkis et al., 2007).  
The data about morphological and ultrastructural features, GC and gametes stage-specific 
proteins expression and GC epigenetic modification pattern are incomplete and need to be 
deepened (Aflatoonian and Moore, 2006; Nagy et al., 2008; Hua and Sidhu, 2008; Marques-
Mari, 2009). Meiosis is pre-requisite for functionally normal gametes formation and its 
investigation is indeed insufficient (Novak et al., 2006; Kerkis et al., 2007). A single attempt 
was made to demonstrate the functional state of gametes obtained from mES cells. It 
showed that the integration of artificial gametes with genetic material of normal eggs 
theoretically can occur. However, live offspring, which were obtained in this study died 
soon after birth (Nayernia et al., 2006). Therefore, experiments of other research groups are 
needed in order to confirm this study. 
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Fig. 4. Presumptive male GC and gametes derived from ES cells. 
This chapter is focused on critical discussion of the actual achievements on GC and gametes-
like in vitro generation from pluripotent stem cells, such as, mES and human embryonic 
stem (hES) cells (Evans & Kaufman 1981, Martin 1981, Thomson et al., 1998) and 
reprogrammed cells: induced pluripotent (iPS) cells (Takahashi & Yamanaka 2006) and 
somatic cell hybrids (Mittmann et al., 2002; Lavagnolli et al., 2009).  
2. Embryonic stem cells 
The ES cells are derived from early embryo, more precisely from morulae or inner cell mass 
(ICM) of blastocysts. ES cells can be maintained and expanded indefinitely in culture, while 
retaining their ability to produce all cell types in the body. This ability, which is also 
denominated as a pluripotency, is an extremely important property of ES cells. These cells 
are growing in monolayer and express in undifferentiated state a set of pluripotent markers 
among which Oct3/4, Nanog and Sox2. The mES cells additionally require leukemia 
inhibitory factor (LIF) in order to maintain undifferentiated state. Differentiation potential of 
ES cells provides a unique tool to generate various cell types in vitro and represent unlimited 
experimental model to study cell lineage commitment, which can be modified by cell culture 
conditions, external factors and spatial orientation (Evans & Kaufman 1981, Martin 1981, 
Thomson et al., 1998).  
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2.1 Differentiation assay  
Generally two basic methods are used for GC differentiation from ES cells. One of them 
consists in adherent ES cell culture and differentiation after removing factors that promote 
pluripotency as feeders and basic fibroblast growth factor (bFGF) or LIF (Hübner et al., 2003; 
Nayernia et al., 2006b; Novak et al., 2006; Chen et al., 2007), whereas the second one 
implicates with the formation of three-dimensional structures known as EB, which further 
allowed to adhere on plastic dishes and differentiate (Clark et al., 2004; Geijsen et al., 2004; 
Lacham-Kaplan et al., 2006; Kerkis et al., 2007). Wei et al., (2008) compared GC, which were 
derived via attachment culture technique and via EB method. They demonstrated that the 
process of PGC derivation was more faithfully recapitulated using the EB method. Next, the 
ES cells can undergo spontaneous or induced differentiation. Spontaneous differentiation 
occurs in ES cells culture medium without MEF or growth factors besides those present in 
heat-inactivated serum, while induced differentiation required addition of growth factor or 
other chemicals: e.g. bone morphogenic protein 4 (BMP-4) or retinoic acid (RA) are usually 
used to induce GC differentiation in vitro. RA is a potent growth activator of mouse PGC 
(Koshimizu et al., 1995). During gametogenesis, the exposure to RA controls the progress of 
GC through meiosis and the differentiation of GC into male or female phenotypes 
(McLaren, 2003; Bowles et al., 2006; Bowles and Koopman, 2007; Doyle et al., 2008). 
2.1.1 Derivation of female GC and artificial gametes 
For the first time female GC were obtained in vitro by Hübner and colleagues (2003), which 
used female mES cells carrying gcOct4-GFP gene reporter. Prior differentiation experiments 
these cells were tested in transgenic animals and expression of gcOct-4-GFP gene in GC but 
in blastocyst or epiblast-stage embryo were not demonstrated. These cells were maintained 
adherent in ES cells culture medium without any feeder cells or growth factors besides those 
present in heat-inactivated serum. Large cell colonies, which formed by day 12 (d12) were 
composed by cells expressing GFP+ or GFP+/ Vasa+ or Vasa+ suggesting a presence of 
premigratory, migratory and early postmigratory GC. Vasa+ cells, which were physically 
separated from each other, detached simultaneously from large colonies and form small 
floating aggregates. Further these aggregates were collected and transferred in new plates 
where they were cultured for 2 weeks forming adherent or floating three dimensional 
follicle-like structures. The expression of growth differentiation factor 9 (Gdf-9), which is 
required for ovarian folliculogenesis, was observed between d16 and d22. Floating follicle-
like structures collected at d26 did not express Gdf-9 indicating that follicular growth was 
completed. Two of three zona pellucida (ZP) proteins ZP2 and ZP3 were detected between 
d16 and d30. The lack of ZP1 expression could be because of thin and fragile zona of the ES-
derived oocytes. Blastocyst-like structures were found at about d43, suggesting spontaneous 
parthenogenetic activation. These structures expressed a set of stage-specific molecular 
trophectodermal markers, such as Hand1, Pl-1, Mash-2 and TpBp. Morulae-like structures 
showed signal of Oct-4 protein with appropriate nuclear localization, which differs from GC 
where Oct-4 localizes in the cytoplasm (Hübner et al., 2003; Salvador et al., 2008). Native 
mES cells (XY) without any genetic modification also were able to produce putative oocytes. 
The EB were obtained and cultivated adherent on the plastic dish, in a testicular cells 
conditioned medium, once testis of newborn males contain most growth factors required for 
the transformation of germ stem cells into differentiated GC. At about 2 weeks oocyte-like 
cells surrounded by one to two layers of flattened cells were obtained, which expressed 
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Vasa protein as well as Oct4, Dazl and Stella. Although they did not have visible pellucid 
zone, a structural hallmark of maturing oocytes, the expression of oocyte-specific markers, 
such as Fig-α, Stra-8 and ZP3 were detected (Lacham-Kaplan et al., 2006; Quing et al., 2007). 
Novak and colleagues (2006) induced differentiation of native ES cells toward female GC by 
their cultivation in ES cells culture medium without LIF and MEF. Under such conditions 
EB were formed around d7. These EB produced cells of variable morphology, which after 
detaching from EB form floating aggregates. Follicle-like structures derived from the 
aggregates were observed from day 18 and afterward, which expressed several oocyte-
specific markers.  
Our group contributed to these studies demonstrating that male ES cells can generate both 
female and male (described below) presumptive GC and gametes (Kerkis et al., 2007). In 
contrast to previous studies, which used the same ES cells basal culture medium, we used 
serum-free B27/neurobasal medium for differentiation. This medium supported the growth 
and long-term viability of nearly pure populations of neural cells without the need of any 
feeder layer. It contains hormones in its composition, which can enhance differentiation 
process. Thus, we suggested that serum-free B27/neurobasal medium can provide 
additional advantages. First, the EB were obtained by hanging drop technique in ES cells 
basal culture medium. Further, they were transferred into serum-free B27/neurobasal 
medium supplemented with RA. Under such conditions non adherent EB were cultivated 
for additional 4 days. RA was removed and the cells were further maintained in serum-free 
B27/neurobasal medium. After 9 days floating EB started to aggregate. The structure 
composed by several EB underwent further differentiation and within 10–15 days inside EB 
aggregates the formation of follicular-like structures and of presumptive germinal vesicle 
has occurred. Floating oocyte-like structures were also found and they expressed Dazl 
protein, which is overexpressed in normal oocyte during GV-MI–MII (Assou et al., 2006). 
Although we did not expect to observe spontaneous in vitro fertilization of the oocyte-like 
structure by the presumptive sperm cells, both formed in the same Petri dish during the 
process of differentiation, we could identify structures resembling fertilized oocyte with two 
pronuclei. These “fertilized” oocytes underwent further development into morulae, 
blastocyst-like structures with well defined but fragile zona pellucida, and hatching 
blastocyst-like structures. The expression of the genes Gdf9, Zp2, and Zp3, which are 
indicative for female GC differentiation, was detected. In accordance to Hübner et al., (2003), 
Zp1 did not express in those structures. For about 25 days, the blastocyst-like structures, 
attached on the monolayer of differentiating ES cells and formed the cell layer resembling 
trophoblasts with inner cell mass. This supposed pre-embryo expressed Oct-4 in the inner 
cell mass-like cells (inside), while trophoblast-like cells (outside) expressed Mash-2 
(mammalian achaete-scute homologous protein-2) protein, which is specific for 
extraembryonic trophoblast lineage (Fig. 5). It is worth mention, that estradiol (~189.0 
pg/ml) was found in culture medium used for ES cells differentiation. It is not included in 
serum-free B27/neurobasal medium composition, suggesting that it was produced by 
differentiated GC. Hübner et al., (2003), also reported estradiol production (50–100 pg/ml) 
after 12 days in mES cell cultures that generated follicle-like structures.  
2.1.2 Derivation of male GC and artificial gametes 
In order to produce male GC from mES cells Toyooka et al., (2003) generated knock-in mES 
cells, in which GFP or lacZ was expressed from the endogenous mouse vasa homolog 
(Mvh), which is specifically expressed in differentiating GC. The EB formation occurred  
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Fig. 5. Female GC development (follicle-, oocyte-, blastocyst- and zygote-like). 
when these cells were cultivated in suspension in a LIF-free medium. The knock-in cells, 
which expressed the reporter gene products clustered together at the periphery of the EB by 
days 5–7.  The Mvh+ cells purified (flow cytometry) from EB were equivalent to in vivo fetal 
gonad GC. Then, Mvh+ cells were aggregated within male genital ridge cells of wild-type 
embryos. Following implantation into adult mouse testis, the cell aggregates composed by 
Mvh+ positive cells undergo further maturation, formed seminiferous tubules-like structures 
that have a capacity to support complete spermatogenesis and to produce mature putative 
sperm cells. Additionally, the authors also found that the exposure of EB to Bmp4 led to the 
emergence of Mvh+ cells within 24 hours. Although the ability of spermatozoa to activate 
eggs was not examined, this study suggested that the germ line specification and the 
emergence of postmigratory PGC can occur spontaneously or be induced in EB, which can 
be completed in testis environment. Geijsen et al., (2004) isolated GC from male ES cells 
carrying EGFP reporter gene. The EB were produced in basal medium and after 7 days of 
cultivating, RA was added for additional 5 days. After RA removal the EB were collected by 
day 20-22. The FEJ1 antibody (Fenderson et al., 1984) was used in order to identify haploid 
round-spermatid-like cells. The positive cells for this marker and EGFP+ were further 
selected by flow cytometry and intracytoplasmatic injection into recipient oocytes was 
performed. These presumptive GC were capable of generating diploid blastocysts, which 
did not undergo further development. Although the isolated cells did not produce cells 
resembling spermatozoa and analyses of further embryonic development was not complete, 
this study suggested that male PGC aroused from ES cells can become postmeiotic cells 
capable of eggs activating. Nayernia et al., (2006) reported not only the induction of male 
gametes from ES cells but also the production of offspring; however this work should be 
carefully evaluated (Daley, 2007). They modified genetically ES cells in order to obtain 
spermatogonial stem cells (SSC). First, they introduced a promoter (Stra8) active in early 
male GC linked to a marker gene encoding EGFP. The selected cell population 
Stra8+/EGFP+ already had the characteristics of male PGC ready to enter the initial stages of 
meiosis. In order to enrich this cell population the cells were further cultivated for 10 days in 
the presence of RA and 8-10 weeks in RA-free culture medium. Next RA was added 12 
hours following selection of EGFP cells. Then authors performed another round of selection 
by introducing the promoter of a gene expressed in more mature haploid male GC (Prm1) 
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linked to another fluorescence marker gene, dsRED. Two genetically modified SSC cell lines 
were established and designated as SSC7 and SSC12. For differentiation, the cells were 
cultured on gelatine-coated dishes, without LIF. The appearance of red fluorescent cells 
suggested that the emerging haploid cells had undergone the final stages of 
spermatogenesis. Nayernia et al., (2006) claimed that they established SSC cell lines that 
undergo meiosis and produce male gametes after only 72 hr. The shape of the resulting 
sperm was, however, abnormal. They injected these presumptive sperm cells into eggs. 
When the resulting 65 embryos were transferred to surrogate mothers, seven live pups 
carrying the Prm1-reporter gene were derived, which apparently had growth abnormalities 
and died short time after birth. Certainly, the production of progeny needs to be confirmed 
by other laboratories.  
We demonstrated generation of male GC from XY ES cells without the use of any genetic 
modification or pre-selection (Kerkis et al., 2007). In our experiments the spermatogenesis –
like process took place between 9 and 11 days: EB were obtained using “hanging drop” by 
day 3, then they were kept floating and RA was added for additional 4 days. During this 
period we already observed migration of presumptive PGC from EB surface and formation 
of aggregates composed by different cell types, such as spermatogonia, spermatocytes, 
spermatids and sperm-like cells between 9 and 11 days.  We described that gamete-like cell 
formation occurred in the correct manner based on the expression of early and late GC 
specific genes, such as Oct-4, Mvh, Stella, Dazl, Piwil 2, Pdrd 1, Rex 14, Rnf 17, Bmp8b, 
Acrosin, Stra-8, Haprin, LH-R, Gdf9, Zp3, Zp2, Sycp1 and Sycp3. Our immunofluorescence 
analysis of morphologically well-formed GC and presumptive gametes showed positive 
labeling with SSEA-1, Oct-4, EMA-1, FE-J1, Dazl, Fragilis, Mvh, Acrosin, and acetylated α-
tubulin (Fig. 6).  
 
 
Fig. 6. Morphological aspect of male GC formation and immunocytochemistry analyses for 
acrosin (green) and alpha-tubulin (red). 
Routine cytogenetic analysis demonstrated that GC were able to undergo chromosome 
reduction, since diploid and haploid chromosome plates were detected. Moreover, we 
presented undiscussable proofs of sperm-like cells formation in vitro, which are 
morphologically similar to normal ones. Electron microscopy images showed acrosomal 
phase of differentiation, which presented by elongated and flattened nucleus, acrosomal 
granule has become the acrosome and it follows the shape of the nucleus, tail filaments 
called axoneme further elongate and mitochondria aggregate about the axoneme cytoplasm 
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is moved by a cylindrical sheath of microtubules called the manchette in the area of the 
developing tail. At maturation phase, we observed final formation of sperm and residual 
body (Fig. 7).   
 
 
Fig. 7. Transmission electron microscopy of male GC formation. 
2.1.3 Fate determination during XY ES cells differentiation into GC  
During murine and human ES cells culture, markers of female GC are expressed in both XX 
and XY cell lines (Toyooka et al., 2003, Hübner et al., 2003; Geijsen et al., 2004, Clark et al., 
2004; Nayernia et al., 2006: Kerkis et al., 2007; Lavagnolli et al., 2009). Previous studies 
involving XX3 XY mouse chimeras have shown that GC whether XX or XY were able to 
enter meiosis in developing ovary, but not in testis, suggesting that initial sex determination 
depends on environment rather than on chromosome composition (Palmer and Burgoyne, 
1991; McLaren, 2003).  For that reason, both male and female ES cell lines can display female 
germ cell markers, since culture conditions may be sub-optimal and lack meiosis inhibition.  
Recently it has been shown, that GC in order to enter meiosis responds to the external signal 
of RA and its metabolism, (Bowles et al. 2006, Koubova et al., 2006). Thus, in the embryonic 
mouse ovary, RA induces germ cells to express the pre-meiotic marker Stra-8 (stimulated 
by) retinoic acid and initiate meiosis. By contrast, in the embryonic mouse testis, RA is 
metabolised and inactivated by the P450 enzyme CYP26 (B1) thereby preventing early germ 
cell entry into meiosis with down-regulation of genes such as SCP3 (synaptonemal complex 
protein; associated with meiotic events). Therefore, the induction of presumptive PGC into 
meiosis in culture medium containing RA might be expected although local concentrations 
within cell aggregates may differ significantly and affect the timing. However, the 
sensitivity of cells to RA can vary considerably depending on composition of medium. 
3. Putative male and female GC and artificial gametes derived from mouse 
reprogrammed cells 
Cell fusion between embryonic stem (ES) and somatic cells usually yields ES-somatic cell 
hybrids (ES-SCH), which retain pluripotency in spite of the presence of ‘‘somatic’’ 
chromosomes in their genomes (Fig. 8). These reprogrammed near-diploid ES-SCH shows a 
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developmental potential similar to ES cells: they express molecular ES cell markers, present 
reactivation of the X chromosome, form EB in vitro and produce chimeras with contribution 
to different tissues (Mittmann et al., 2002; Vasilkova et al., 2007). 
Our group was the first to show that reprogrammed cells obtained from the fusion of mES 
cells and mouse splenocyte were also able to undergo GC differentiation in vitro (Lavagnolli 
et al., 2009). Differentiation of ES-SCH was induced through EB formation and by the 
addition of retinoic acid following previously described protocol (Kerkis et al., 2007). 
Presumptive GC obtained reacted positively with anti-EMA, Vasa, Fragilis and Dazl 
antibodies and expressed GC-specific genes, such as Vasa, Stella, Dazl, Piwil2, Tex14, 
Bmp8b, Tdrd1 and Rnf17. Fluorescent in situ hybridization analysis (FISH) indicates 
chromosome reduction in the GC-like cells. Expression of meiotic and postmeiotic GC-
specific genes such as Haprin, Acrosin, SYCP1, SYCP3 and Stra-8 was also detected. 
Transmission electron microscopy confirmed ES-SCH differentiation into presumptive GC. 
The presence of several autosomes and the X chromosome originated from the ‘‘somatic’’ 
partner did not prevent ES-SCH differentiation towards presumptive GC. Overall our study 
suggests an interesting in vitro model, which allows the study of GC differentiation in 
reprogrammed somatic cells. This study represents significant advance, showing future 
prospect to obtain partly patient-matched GC and gametes. 
 
 
Fig. 8. Somatic cells reprogramming by fusion 
4. Putative GC derived from hES and induced pluripotent stem cells  
The ability of hES cells to enter the germ line was examined by Clark and colleagues (2004). 
This and further studies, based mainly on molecular analysis of stage specific genes 
expression, suggested that hES cells of both sexes may spontaneously through EB formation 
generate presumptive GC and supposedly undergo meiosis  (Clark et al., 2004, Aflatoonian 
et al., 2005). More recently other groups improved previous protocol by the addition of 
growth factor in order to improve GC differentiation within the EB (Kee et al., 2006; Tilgner 
et al., 2008; West et al., 2008; Park et al., 2009). The molecular analysis revealed the 
expression of the germ-line stage-specific genes (e.g., VASA, DAZL) and of the meiotic 
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marker (SYCP3). However, expression of germ-line stage-specific proteins was only 
marginally studied (West et al., 2008, 2010). Until now, only two studies showed the image 
of follicular-like structures appearing within monolayer or EB of differentiated ES cells 
whose morphology resemble those of normal oocytes (Chen et al., 2007; Aflatoonian et al., 
2009). The first study did not present any evidences if they do indeed oocytes-like structures 
(Chen et al., 2007), while other failed to detect expression of ZP proteins in these structures 
(Aflatoonian et al., 2009). Induced pluripotent stem (iPS) cells are differentiated somatic cells 
reverted to a pluripotent state. After reprogramming, they acquire properties of ES cells in 
morphology, proliferation, gene expression, epigenetic profile, and differentiation potential 
(Takahashi & Yamanaka, 2006, Takahashi et al., 2007). This approach would allow the 
creation of patient-specific cells, which is advantageous for cell therapy due to immune 
compatibility. The derivation of GC from human (h)iPS cells constitutes both a desirable 
model for reproductive geneticists, and a potential method for treating couples with 
infertility due to germ cell defects. It has been shown that derivation of GC from (h)iPS cells 
following 7 days of differentiation results in the generation of immature GC corresponding 
to a developmental stage in vivo between specification and less than 9 weeks of gestation 
(Park et al., 2009). However, the doubts about the usefulness of (h)iPS cells for GC 
generation raised by the study of massive epigenome reorganization. It was unclear whether 
reprogramming of female human cells reactivates the inactive X chromosome (Xi), as in 
mouse. In order to clarify this question, (h)iPS cells were derived from several female 
fibroblasts under standard culture conditions carrying a Xi. These cells showed the lack of Xi 
reactivation. This finding critically implicates with the use of (h)iPS cells for clinical 
applications and disease modelling, and could be exploited for a unique form of gene therapy 
for X-linked diseases (Tchieu et al., 2010). Furthermore, (h)iPS and hES  are distinguished by 
gene expression signatures (Chin et al., 2009). Overall, the methodologies of hES cells derived 
presumptive GC and gametes characterization are often limited to molecular profile of genes 
expression involved in GC specification leaving aside the other important characteristics. 
Therefore, derivation of GC from hES and (h)iPS cells is still at initial stage. 
5. Timing of in vitro ES-derived GC differentiation  
The genes involved in the differentiation of the three germ layers, and genes specific for 
several cell lineages are expressed in EB over the same time period as in gastrulating 
embryos. In contrast, all studies showed that derivation of GC from ES cells takes place 
much faster in vitro than in vivo. Several studies showed that ES cells in culture have already 
acquired the capacity to form PGC expressing a set of PGC genes in undifferentiated state 
e.g. PGC founder-specific genes Stella and Fragillis are detectable in ES cells before the onset 
of differentiation, whereas those genes are not expressed in the inner cell mass and early 
epiblast cells in vivo (Aflatoonian and Moore, 2006; Ko & Schöler, 2006; Nagano., 2007; 
Daley, 2007; Hua and Sidhu, 2008; Marques-Mari, 2009). The environmental factor can also 
influence the timing of differentiation, therefore progression of PGC differentiation may be 
suppressed in the embryonic environment until the PGC reach an appropriate position near 
the developing gonads. Additionally, some of the factors that regulate the timing of PGC 
differentiation in the embryo are absent from in vitro culture systems. The discrepancies in 
timing observed in different studies may be related with properties of ES cell lines and 
culture conditions used in each work.   
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6. Molecular characterization of putative GC 
Independently of the methodologies of ES cells differentiation toward GC, the molecular 
characterization is indispensable. Using simple or sophisticated methods, the studies need 
to show an expression of PGC markers (specification and specific gametogenesis) during 
development of both types of gametes. Understanding of PGC molecular mechanisms of 
differentiation and fate is important to elucidate infertility causes. The molecular analyses 
are an important tool to characterize this complex process, which is necessary not only to 
confirm a success of applied protocol, but also to evaluate their efficiency and effectiveness. 
In table 1 we summarized information about genes markers for different stages of 
gametogenesis used in different studies. A careful study of in vitro PGC specification is 
difficult by the fact that mammalian in vivo or in vitro cultured PGC derived from native 
tissues and ES cells shared a significant number of markers e.g. Oct4 and SSEA1. In 
addition, PGC markers, such as Blimp1, Mvh, Fragillis and Stella and even GC markers, 
such as Piwil2, Rnh2, Tdrd1 and Tex14, are also detected in undifferentiated ES cells. 
Among these markers Stella was appointed as an excellent marker to be used for cell sorting 
of GC in vitro (Wei et al., 2008). A systematic analysis of single cell showed a gene 
expression dynamics in GC line during PGC specification in vivo and revealed differential 
pattern of several genes expression between ES cells and PGC e.g. Eras, T and Fgf8 (Yabuta 
et al., 2006). A core of genes as Oct4, Sox2, and Nanog which regulates pluripotency in stem 
cells also performs an important role in GC development regulation. The repression of this 
core machinery regulating pluripotency is an early event involved in differentiation of GC. 
Furthermore, in mice fetal male-specific germ line methylation of functional elements as 
Nanog and Sox2 promoters and genes was shown suppressed during early male GC 
differentiation. The Oct4 translation is suppressed post-transcriptionally following male GC 
differentiation allowing entrance in the mitotic arrest (Western et al., 2010). Therefore, the 
determination of single cell PGC and GC molecular markers in a challenge for the future 
studies will allow improving currently established protocols of both GC derivations from 
appropriate tissues and from ES cells in vitro.  
 
Specification 
Blimp1        ■ 
Bmp8b  ■     ■  
C-kit ■    ■ ■■  ■ 
Ddx4     ■    
eFgls  ■ ■  ■  ■  
Fgf8        ■ 
Nanog        ■ 
Oct4 ■ ■ ■ ■ ■ ■■ ■■ ■■ 
Piwil2   ■  ■  ■  
Rbm     ■■    
Rnf17   ■  ■  ■  
Rnh2   ■      
Sox2        ■ 
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Sox17        ■ 
Stella  ■ ■  ■ ■ ■ ■ 
Tdrd1   ■    ■  
Tex14   ■    ■  
SSEA1   ■ ■   ■  
 
Gamete determination 
Dazl   ■  ■ ■ ■■  
Stra8     ■■ ■ ■  
Vasa (Mvh) ■■ ■■   ■ ■■ ■■ ■ 
 
Gametogenesis 
Acrosin     ■  ■■  
Acetylated ǂ-tubulin       ■  
Dmc1 ■    ■    
DsRed (condesen Nuclei)     ■    
Ema-1       ■  
FE-j1   ■    ■  
Figǂ      ■   
Gcna1 (Meiosis)  ■       
Gcnf   ■      
Gdf9 ■      ■  
Haprin   ■    ■  
hnRNPGT (sperm meiosis)     ■    
Hsp90ǂ     ■    
Oam (sperm pos meiotic)     ■    
Prm1 (Pos Meiotic)     ■     
Rec8 (Meiosis)    ■     
Scp1 (Meiosis)    ■   ■  
Scp2 (Meiosis)    ■     
Scp3 (Meiosis) ■■ ■  ■ ■  ■  
Smc1-ǃ (Meiosis)    ■     
Stag3 (Meiosis)    ■     
Tp2 (Pos Meiotic)***     ■■    
Zp1   ■   ■ ■  
Zp2 ■  ■   ■ ■  
Zp3   ■   ■ ■  
■ RT-PCR  ■ Immunoassay 
1– Hübner et al. (2003); 2 – Toyooka et al. (2003); 3 - Geijsen et al. (2004);  4 – Novak et al. (2006),  
5 - Nayernia et al. (2006); 6 – Lacham-Kaplan & Trounson (2006); 7 – Kerkis  et al. (2007), 8 – Wei  et al. 
(2008). 
Table 1. Markers of GC differentiation. 
Studies 1 2 3 4 5 6 7 8 
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7. Epigenetic modifications of ES derived GC 
An important emerging theme from recent studies is that epigenetic modification can be 
implicated in GC development itself, contributing to the gene expression program that is 
required for GC development, regulation of meiosis and genomic integrity. Understanding 
of epigenetic regulation in GC has implications for reproductive engineering technologies 
and human health. 
Epigenetics has been defined as a collection of mechanisms and phenomena that will 
generate the phenotype without affect the genotype. The mechanisms involved in this 
regulation are represented by a range of chromatin modifications, including DNA 
methylation, histone modifications, remodelling of nucleosomes and higher order chromatin 
reorganization. These epigenetic modifications define a cellular identity regulating gene 
expression and are unique in each cell. Epigenetic profiles are adjustable during cellular 
differentiation, but remains inherited: it ensures that daughter cells have the same 
phenotype as the parental cell (Goldberg et al., 2007).    
The process of GC development is regulated by both genetic and epigenetic mechanisms. 
This type of cell can give rise to a new organism. Therefore, during fertilization, the 
products of GC development - the oocyte and sperm cell, fuse to form a zygote, which is 
considered totipotent. To acquire this totipotency, the GC and the zygote undergo to 
extensive epigenetic reprogramming. In mammalian GC, reprogramming also erasure the 
existing parental imprints and establishes new ones, which are different in male and female 
gametes. Genomic imprinting gives rise to differential expression of paternally and 
maternally inherited alleles of certain genes. Thus, unlike most genes in our genome, which 
are either expressed or silenced from both parentally inherited alleles (biallelic expression), 
monoallelic expression of imprinted genes occurs in a tissue and developmental stage-
specific manner during development (Allegrucci et al., 2005; Reik, 2007). Imprinted genes 
comprise a small subset of the genome, perhaps 100 out of the total 30 000 genes whose 
epigenetic reprogramming in the germ line is imperative for subsequent normal 
development of the embryo (Miozzo & Simoni, 2002). Almost all these imprinted genes 
could be used as a strategy to confirm the potential status of GC differentiation.  
The role of epigenetics in GC and in somatic cells occurs in different way. During somatic 
cell differentiation, cells initiate in a pluripotent state followed by decision of their fate, 
being able to originate a range of different cell types (Reik, 2007). Their gene-expression 
profile become more restricted and potentially protected from epigenetic modifications. On 
the other hand, GC are different in that, because their fate has been determined during early 
development. The GC have specific fate suffering a series of epigenetic events that are 
unique to this cell type. GC undergo meiosis and the particular importance of maintaining 
genomic integrity. It is important to study how imprints are re-established in the male and 
female GC and their contributions to GC-specific functions at each stage. 
Recent studies have shown that changes in epigenetic modifications also have important 
roles in the regulation of post-migratory PGC-specific genes. Genes such as Ddx4 (also 
known as Mvh), Sycp3 (synaptonemal complex protein 3) and Dazl (deleted in 
azoospermia-like) are induced after migrating of PGC toward genital ridge. DNA-
methylation analysis revealed that, despite the genome-wide decrease in DNA methylation 
after E8.0, the flanking regions of these genes remain methylated at E10.5, but become 
hypomethylated by E13.5 when they are expressed. The results suggest that DNA 
methylation regulates the timing of activation of these genes. In mice, when PGC arrive at 
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the genital ridge (E11.5), they undergo extensive epigenetic reprogramming, including the 
erasure of parental imprints. The erasure of imprints is reflected by demethylation of the 
imprinted loci, which occurs concomitantly with demethylation of other regions. Once the 
parental imprints have been erased, new imprints must be re-established according to the 
gender. This re-establishment occurs only after sex determination has been initiated, and 
male and female GC development diverges to give rise to sperm or oocytes, respectively 
(review in Sasaki & Matsui, 2008). It should be considered  the GC formation from ES cells.  
Another important event that occurs in mammalian female cells is the X-chromosome 
inactivation. In somatic cells of female mammals, one of the two X chromosomes is 
inactivated so that the dosage of the genes on this chromosome is equalized between males 
and females. The inactive X chromosome is reactivated during female GC development. 
Extensive studies have been made to understand when this mechanism occurs and how 
they can be maintained by the generation. It had been thought that this reactivation occurs 
around the time of imprint erasure (Monk & McLaren, 1981; Tam et al., 1994) However, 
more recent studies showed that it is initiated in the migratory stage (de Napoles et al., 2007) 
or at an even earlier stage (Sugimoto & Abe, 2007). Therefore, X-chromosome reactivation 
occurs in a progressive manner in prolonged period and is completed in post-migratory 
PGC.  
Geijsen et al., (2004) showed in their experiments haploid round spermatids displayed 
somatic-like imprinting status of the Igf2r and H19 genes by day 4 of differentiation. The 
imprinting methylation profile was erased by day 7, demonstrating that the PGC derived 
from EB may be able to mimic the epigenetic reprogramming features of PGC developing in 
vivo. Nayernia et al., (2006) obtained sperm cells, which were able to fertilize oocytes after 
ICSI resulting in a number of pregnancies, although the majority died in uterus, the others 
development to term. The resultant pups, however, had abnormalities in DNA methylation 
at imprinted loci and survived only up to five months, indicating that reprogramming of the 
GC genome was not properly accomplished. 
Recently, Kee et al., (2009) explored adherent differentiation of human ES cells carrying 
VASA-GFP reporter in the medium supplemented with or without BMP4, and observed that 
both XY- and XX-bearing human ES cells (approximately 0.8–5%) reproducibly gave rise to 
PGC. The epigenetic status was analyzed and showed erasure of methylation 
(hypomethylation) globally and at the differentially methylated regions (DMRs) of 
imprinted loci. The authors found that the H19 locus was hypomethylated in GFP1 cells 
relative to GFP2 cells. Results from other imprinted loci (PEG1/MEST, SNRPN, and KCNQ) 
confirmed that the GFP1 cells also showed significantly lower levels of methylation at these 
DMRs relative to other cell types. Furthermore, examination of global DNA methylation 
levels provided strong evidence that the VASA–GFP1 population was in the process of 
erasing methylation globally. When DAZL and BOULE were overexpressed in XX human 
ES cells, PGC formation was enhanced suggesting potential formation of haploid gametes.  
Regarding to iPS cells, Park e co-workers (2009) showed that VASA expressed during germ 
cell formation in the first trimester of human development in vivo. They used these surface 
markers to isolate putative (h)iPGC from hES cells and (h)iPS cell lines after differentiation 
on primary human fetal gonadal stromal (hFGS) cells in vitro. They found that imprinting 
control center that were differentially methylated in undifferentiated hES cells (H19 and 
SNRPN in HSF-1 and H19, PEG1, and SNRPN in HSF-6) initiated the process of imprint 
erasure by day 7 in the iPGC. However, (h)iPGC derived from hIPS cells do not initiate 
imprint erasure as efficiently. Regarding Xi, these (h)iPGC showed the lack of Xi 
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reactivation. This work suggests that GC originated from iPS cells are not as efficiently as 
from ES cells in the epigenetic remodelling. If these results will be confirmed by other 
studies, it could be a barrier in case of therapy of infertility using iPS cells to produce 
gametes in infertile patients.   
When we fully understand the complete mechanisms of germ-cell reprogramming, we 
might be able to derive appropriately reprogrammed and functional gametes from cultured 
cells. This will allow new approaches to reproductive engineering, although ethical and 
safety issues must be carefully considered. 
8. Meiosis in ES derived GC 
The meiotic process is an essential step in the gamete formation in organisms with the 
system of sexual reproduction and this process is indeed studied inadequately. A better 
understanding of the meiosis and its regulation, together with advances in genomics, will 
allow us to predict a perfect establishment of fertility disorders. Meiosis is a cellular division 
mechanism based on separation and diminishes of the chromosomal set followed by 
haploid cells formation (gametes). In eukaryotes is characterized by an extended prophase, 
followed by two divisions. A sexual meiosis dimorphism should be considered: first, in 
male, one single cell that enters in meiosis can produce four haploids gametes (sperm cell). 
On the other hand, in the female, one single cell will originate only one gamete (oocyte), 
which completes second division after the fertilization (Fig. 2).  
Meiosis is preceded by DNA replication in a pre-meiotic S phase, usually longer than 
mitotic S phase. The pre-meiotic DNA replication generates primary gametocytes; each 
chromosome is comprised of two chromatids (4C DNA content). The S phase is proceeded 
by the long meiosis I prophase (this phase is divided in other four substages), during which 
homologous chromosomes starts to be paired and undergo recombination in a series of 
events that define the substages of meiosis I prophase. This crossing-over (CO) 
recombination in meiosis is required to guarantee an accurate segregation of homologous 
chromosomes at the first meiotic division. The absence of CO can result in random 
disjunction (separation of chromosomes or chromatids during anaphase of mitosis or 
meiosis) and might form an aneuploidy gamete, that may leads to embryonic death or 
developmental abnormalities (review in Handle & Schimenti, 2010). In fact, aneuploidy 
present in gametes is a principal cause of birth defects in humans. Most of these 
aneuploidies are formed during oogenesis, mainly during the first meiotic division, and the 
frequency of such errors increases with female age (Hassold et al., 2007).  
The substages of meiosis I prophase are defined by chromosome configurations and 
structure: pairing, which occurs during the leptotene and zygotene stages. These events are 
accompanied by synapsis, a process that is mediated by a specialized meiotic structure, the 
synaptonemal complex (SC).  The recombination structure is defined by the formation of a 
chiasma (the point that the chromatids of the homologous chromosomes undergo the 
recombination - exchange). The first meiotic division (metaphase I, followed by anaphase I 
and telophase I) is reductional and separation homologous chromosomes, producing 
secondary gametocytes.  Each gametocyte has haploid chromosome content in which still 
comprised of two chromatids). In male gametogenesis, it results in two secondary 
spermatocytes and in females it results in one secondary oocyte and a polar body. The 
second meiotic division — an equational division, separates sister chromatids. This phase is 
also sexually dimorphic, but in this case in both of timing and in the products formed. In 
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males it occurs immediately after the first division and the chromatids are separated and 
produce four haploid immature spermatids that contain the haploid chromosome number 
and 1C DNA content. In female GC, the timing of the second meiotic division is coordinated 
with ovulation and occurs after fertilization, producing a haploid oocyte (fertilized egg) that 
contains two haploid pronuclei, one paternal and the other maternal as well as three polar 
bodies  (review in Handle & Schimenti, 2010). 
Based on the architecture of the meiosis, the chromosome pairing and the CO are crucial for 
the appropriate segregation of homologous chromosomes at the first meiotic division of 
most organisms. The fidelity of recombination and chromosome segregation that avoid 
aneuploidy are dependent of the dynamics of chromosome pairing and synapsis during 
meiotic prophase. The chiasma formed by CO events is essential and we can see the 
occurrence of at least one CO per chromosome in humans. This protein structure (lateral 
elements – LE, cohesin REC3 and axial elements – AE, synaptonemal complex (SC)-specific 
proteins, such as SYCP3 and SYCP2 formed in the chromosome pairing) can physically 
maintain chromosome homologues attached during the end of prophase. In this moment, 
the cohesins are removed and the structure progress to the metaphase I and chromosome 
homologue division (Fledel-Alon et al., 2009). Failure of a chromosome pairing to undergo 
at least one CO can result in both homologues segregating to the same daughter cell at the 
metaphase I, leading to aneuploidy.   
A lot is known about of the proteins that contribute to formation of the chromosomal axes and 
the SC, but little is known about exactly how the separable events of pairing and synapsis 
come about, mainly when we consider this events in GC derived from ES cells. Some proteins 
related with this structure such as SYCP1, SYCP2 or SYCP3, cohesins and the telomere length 
of the chromosome have been studied to a better understanding of the meiosis process in the 
GC derived from ES cells. Several reports have demonstrated the formation of oocyte-like 
structures and postmeiotic male GC in embryonic stem (ES) cells culture (Clark et al., 2004; 
Geijsen et al., 2004; Hübner et al., 2003; Lachan-Kaplan and Trounson, 2006; Nayernia et al., 
2006; Toyooka et al., 2003). Molecular analysis of the expression of these genes required in the 
initial and progression of the meiosis and the SC formation have been done suggesting that the 
cell formed in this type of differentiation could be GC in different phases of maturation.  But in 
almost all of these studies the analyses is based on molecular gene profile only or in some 
cases in immunocytochemistry showing the presence of the proteins involved.  According to 
Novak et al., (2006), the meiotic process in germ cell-like cells derived from ES cells probably 
fail to correctly initiate and progress due to the absence of complementary meiotic proteins, 
even though they express SYCP3, indicating that only the molecular expression analysis is not 
enough to confirm the CG formation and maturation. Their results demonstrated that the SC 
did not occur efficiently, and the FISH results revealed two separate signals of same 
chromosome homologue (when the expected are together), which is an indicative of the 
absence of bivalent formation. This study suggested that the chromosome organization of 
these cells was associated to a mitotic division instead of meiotic. Resumption of meiotic 
progress and entry into the meiotic division phase is controlled by somatic cells and in vivo is 
hormonally prompted (Hsieh et al., 2009). In this case described by Novak,  we can suggest 
that the oocyte-like cells did not progress into meiosis due to the fact that the development 
observed in vivo are arrested in prophase I of meiosis I until there is a hormone stimulus that 
triggers their meiosis I accomplishment. We should consider that in their work, it was 
analyzed a low number of follicle-like structures, that could not represent the remaining cells. 
Another important thing is that, in vivo in each cycle a lot of primordial follicles were required 
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in hormone response, but just one completes the meiosis I, being ovulated. In this work, it 
might occur and the samples could represent the oocytes that not complete the meiosis phase. 
The correct segregating chromosomes in meiosis and formation of a haploid cell is a 
prerequisite for the derivation of CG from ES cells in both - animal model of study or 
cellular basement therapy in the treatment of infertility. Our group (Kerkis et al. 2007), 
which showed the occurrence of both types of cells female and male GC in the same culture 
conditions. The cytogenetic analyses demonstrated cells with the chromosomes organized in 
similar manner as during meiosis I. FISH data showed cells with two signals of both X and Y 
chromosomes, as well as, the cells with only one signal of X or Y chromosome in each, 
indicating that the meiotic process occurred (Fig.9). However, both studies (Novak et al., 
2006; Kerkis et al., 2007) are not completely conclusive. Further analyses should be provided 
to explain the details of meiosis. We need to analyze all aspects of meiosis associating them 
with epigenetic modifications. 
 
 
 
Fig. 9. Meiosis progress during male GC differentiation (conventional cytogenetic, molecular 
and FISH analyses). 
Although, the substantial knowledge of PGC and gamete development in the mouse and 
many mechanisms are highly conserved in mammals, little is known about human CG 
formation and there remains necessary to investigate (Moore & Aflatoonian, 2007), mainly 
when we consider the differentiation from ES cells. Although PGC development can be 
formed from these systems, post-meiotic cell phenotypes have been difficult to identify and 
recover. Recently, Kee et al., (2009) used γH2AX (indicator of meiotic recombination) and 
SYCP3 (synaptonemal complex formation in meiotic prophase I) to examine meiotic 
progression and showed low levels of SYCP3 in rare cells and no signal of γH2AX. These 
results indicate that these cells were in a pre-meiotic stage, and rare cells entering in meiosis. 
DNA content analyses by flow sorter showed that less than 2% of the cells were 1N 
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(haploid) confirmed by FISH. This percentage of cells that complete meiosis process is 
consistent with the natural process in vivo. 
Several studies have been characterized the transcriptome during male meiosis in mice 
(Schlecht et al., 2004; Shima et al., 2004), but the regulators of the mammalian meiotic 
program continuous unidentified. Up to now, the major advance was the discovery that the 
onset of meiosis in mice is regulated by RA and is mediated by Stra8 (Bowles et al., 2006; 
Koubova et al., 2006; Bowles & Koopman, 2007). The effect of RA on Stra8 induction and 
initiation of meiosis is sexually dimorphic in timing. In fetal ovaries the RA is secreted by 
the mesonephroi and can induce the Stra8 expression and the GC enter in meiosis. These 
events can be detected by waves of expression of meiotic markers, for example: Dmc1 
(disrupted meiotic cDNA 1 homologue) and Sycp3. The fetal testis are also exposed to RA, 
but the Stra8 expression is not induced because the presence of a CyP26B1 and P450 family. 
This gene is expressed only in Sertoli cells with consequence of male GC do not enter 
meiosis during the fetal life; the entry of GC into meiosis in the adult testis appears to be 
controlled, at least in part, by stage specific expression of CyP26B1. The role of STRA8 and 
RA in the regulatory process of the meiotic initiation in both spermatogenesis and oogenesis 
was confirmed by genetic analysis (Anderson et al., 2008). The regulation of meiotic 
initiation by RA could involve germ cell intrinsic factors, such as the RNA binding protein 
DAZL (deleted in azoospermia-like), which may act upstream of Stra8 in the pathway of 
meiotic induction (Lin et al., 2008).  
Based on these results, the presence of RA and expression of STRA8 and possible the DAZL 
are necessary for the entry of GC in the meiosis in different times of life. In almost all works 
published showing the derivation of germ cell from mES cells have been demonstrated a 
molecular profile of gene expression and in almost all of them, the presence of RA in the cell 
culture is totally necessary for the meiotic progress (review in Kerkis et al., 2007). Nayernia 
and co-workers (2006) developed SSC lines from ES cells able to undergo meiosis and 
capable to generate a functional haploid male gametes in vitro. The authors demonstrated 
the increasing of the expression of Stra8 after the addition of RA in culture. A FACS analysis 
showed that approximately 30% of these cells undergo meiosis and produce a haploid cell 
population after 72 hr of RA induction that was not observed in culture without RA 
induction. The authors showed the formation of SC after electron microscopy analyses. 
Lacham-Kaplan and Trounson (2006) reported the formation of putative oocytes by using 
testicular cells conditioned medium. We showed both types of differentiation, male and 
female CG (Kerkis et al., 2007) in the same culture condition by RA induction. Our results 
demonstrated an increase of gene expression after RA induction and the expression of 
meiosis markers. 
Finally, much effort has been devoted recently to the generation of functional gametes from 
embryonic stem cells or iPS cells. We should consider that mammalian GC are surrounded 
by specialized somatic cells (Sertoli cells and granulosa cells) in which secrete substances 
that influence their homeostasis and meiotic status. For these reasons, it has not been 
completely possible to successfully sustain initiation and continuous execution of all steps of 
meiosis in vitro. In any attempt to generate mammalian gametes in vitro, it will be 
challenging to mimic the roles of the somatic cells that act in both instructive and permissive 
roles to support meiosis and gametogenesis. Any use of in vitro derived mammalian 
gametes must be predicated on rigorous proof of the execution of key steps in meiosis and 
the fidelity of chromosome segregation. 
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9. Functional status of artificial gametes 
The gametes are a key for conservation and preservation of the species (Hua & Shidu, 2008). 
The haploid DNA, generated on gametogenesis, will be joined by fertilization to develop a 
new individual. Due to the importance of this event, the gametogenesis is a complex and 
regulated process, difficult to be mimicked in vitro (Daley, 2009). Spermatogenesis involves 
mitosis, meiosis, spermiogenesis and spermiation, a cascade of events that must occur 
precisely and with the involvement of the Sertoli cells (Wong & Cheng, 2009). After leaving 
the testis, the sperm pass through the epididymis, formed by a pseudo-stratified epithelium 
with several cell types (Cornwall, 2009) and a specific and specialized condition is created.  
The changes in the spermatozoa arising from active secretion and absorption of water, ions, 
organic solutes and proteins, beyond the function of maintaining blood barrier. Besides the 
changes, epididymal secretions maintains the vitality of the sperm, allowing the 
development of motility and protect against harmful agents (Robaire et al., 2006), essential 
for complete maturation of sperm, which involves the development of progressive motility 
the ability to recognize, bind and penetrate the oocyte (Moore, 1990). These modifications 
include changes in composition and biophysical properties of the sperm membrane, 
stabilization of chromatin and other organelles with disulfide bridges, as well as 
morphological changes such as the migration of cytoplasmic droplets (Bassols et al., 2005). 
One mature sperm is mobile, able to perform the fertilization process and support the 
development of a new individual. The maturity of gametes differentiation in vitro was 
hardly questioned (Daley, 2007). Several groups have succeeded in obtaining sperm-like 
cells in different conditions. None of them showed typical progressive motility and nobody 
known whether the culture conditions and differentiation in vitro causes any change such as 
occurs in vivo in the epididymis. In contrast with other studies, we obtained mature sperm 
cells (Fig. 6 and 7); however we also did not succeed to register any sperm motility (Kerkis 
et al., 2007). Embryos (Geijsen et al., 2004) and pups (Nayernia et al., 2006) performed by 
ICSI using sperm-like cells derived in vitro, died quickly, demonstrating that this process 
still have failures. Another important point to consider is the efficiency of gamete 
production in vitro. Rare sperm-like cells are generated, regardless of culture condition and 
genetic manipulation. 
10. Conclusions 
Infertile couples caused by genetic and epigenetic or any other problems which requires 
chemotherapy or radiotherapy, justify the challenge to enlarge our knowledge about the 
complex gametogenesis process and develop diagnostic approaches; gene therapies and any 
other techniques for fertility preservation and treatment. Only the first’s steps were taken. 
The knowledge produced can be used to better understand this complex process - the 
gametogenesis and help these couples studying the failures. Now, we should focus on 
increasing the efficacy of the process and better characterize the cell types produced. In 
animals, is possible to test the functionality of these cells, and see how close the 
differentiation process is from normal. Then, it will be possible to test male contraceptive 
drugs evaluating the toxicity effects of new drugs on the germinal tissue. Another side of 
this promising technology is the application in transgenesis, since stem cells are easily 
genetically engineered and selected. After the process of differentiation, these gametes could 
be used to generate transgenic animals.  
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Differentiation toward gametes represents the extraordinary advances in the developmental 
biology, biology of reproduction, stem cell biology. Further investigation of this amazing 
type of differentiation implicates with great biotechnological progress in regards of genetic 
amelioration of livestock and preservation of genetic fund of the animals in extinction. In 
humans, this research can contribute significantly for understanding of genetic and cellular 
mechanisms of infertility. However, the use of artificial gametes in assisted reproductive 
technologies is implicated with huge ethical problems, which should be well thought and 
discussed before this technique will become a reality in Reproductive Medicine (Testa & 
Harris, 2004).  
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